Mabion S.A. (FRA:272)
Germany · Delayed Price · Currency is EUR 1.734
+0.012 (0.70%)
At close: Nov 28, 2025
Mabion Employees
As of December 31, 2024, Mabion had 213 total employees, including 206 full-time and 7 part-time employees. The number of employees decreased by 34 or -13.77% compared to the previous year.
Employees
213
Change (1Y)
-34
Growth (1Y)
-13.77%
Revenue / Employee
€12,621
Profits / Employee
€72,787
Market Cap
28.09M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 213 | -34 | -13.77% |
| Dec 31, 2023 | 247 | -8 | -3.14% |
| Dec 31, 2022 | 255 | 11 | 4.51% |
| Dec 31, 2021 | 244 | 31 | 14.55% |
| Dec 31, 2020 | 213 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Mabion News
- 5 years ago - Spark Therapeutics Further Strengthens Technical Expertise with Appointment of Cynthia Pussinen as Chief Technical Officer - GlobeNewsWire
- 5 years ago - Spark Therapeutics Announces First Participant Dosed in Phase 1/2 Study of Investigational Gene Therapy for Late-Onset Pompe Disease - GlobeNewsWire
- 6 years ago - GAMCO Investors Exits Viacom, Spark Therapeutics - GuruFocus
- 6 years ago - Regulators Give Roche Green Light For $4.3B Spark Therapeutics Acquisition - Benzinga
- 6 years ago - Roche to complete $4.3 billion Spark deal as regulators give all clear - Reuters
- 6 years ago - U.S. antitrust enforcers give Roche approval to buy Spark Therapeutics - Reuters
- 6 years ago - Spark Therapeutics Wins Prix Galien USA Award for LUXTURNA® (voretigene neparvovec-rzyl) as Best Biotechnology Product - GlobeNewsWire
- 6 years ago - FTC staff recommends approval of Roche deal for Spark: report - Reuters